|
Dr. Singh is one of the leaders in the
field of mitochondria research and medicine.He is Professor of Oncology at Roswell Park Cancer Institute,
the first cancer research, treatment and education center
established in the United States. Prior to joining Roswell Park
Cancer Institute, he was an Assistant Professor of Oncology and
Environmental Health at Johns Hopkins School of Medicine. He is
an expert in mitochondrial genetics and has more than 20 years
of research experience.
Dr Singh founded the Mitochondria Research
Society, is the founding editor-in-chief of the journal
Mitochondrion and is instrumental in promoting Mitochondrial
Research and Medicine around the world. He has organized
scientific meetings and workshops on mitochondria around the
world including the Czech Republic, Russia, India and United
States. He has also chaired or co-chaired several sessions in
international scientific meetings. He is an international
advisor to the Asian Society for Mitochondria Research and
Medicine, Korea and Mitochondrial Physiology Society, Austria.
He serves on the Scientific Advisory Board and the Research
Expansion Project of the United Mitochondrial Diseases
Foundation. Dr. Singh was awarded a Junior Research Fellowship
of Council of Scientific and Industrial Research, India, a
Postgraduate Research Award from University of Wollongong,
Australia, a Summer Fellowship from Marine Biological
Laboratory, Woods Hole, Massachusetts, a Postdoctoral Research
Fellowship from American Heart Association, an Individual
National Research Service Award from National Cancer
Institute, a FIRST Award from National Institute of
Environmental Health, National Institute of Health, and a
Scientist Development Award from American Heart Association.
Dr. Singh serves on the editorial boards of Cancer Biology &
Therapy, Technology in Cancer Research and Treatment,
Nanomedicine, FEMS Yeast Research and Molecular Cancer. He
serves as an expert peer reviewer for several other journals.
He is also an expert reviewer of grants submitted to U.S.
Department of State, United Mitochondrial Disease Foundation,
National Research Council, Canada, Komen Breast Cancer
Foundation, and National Institutes of Health. Dr Singh has
been quoted in articles on the New Scientist, on the web,
(BioMedNet), newspapers, and has given interviews to radio
shows and to Associated Press on Mitochondria stories of
public interest.
Dr. Singh is the founding member of the
American Academy of NanoMedicine. He was appointed as Honorary
Chairman of the Business Advisory Council by the Chairman of
the National Republican Congressional Committee to help
represent issues related to mitochondrial diseases. Dr. Singh
is the author of over 50 research publications, two books
entitled “Mitochondrial DNA Mutations in Aging, Disease
and Cancer” and “Oxidative Stress, Disease and
Cancer”. His translational research is aimed at
developing methods to identify potential "mitomutagens"
present in our environment and agents and methods that can be
used in diagnosis and therapy of cancer. His basic research is
focused on Mitochondrial oxidative stress, genomic instability
and mutagenesis and its role in pathogenesis of mitochondrial
diseases, aging and cancer. |
